Gene Predictis wins the European Venture Contest 2015

Gene Predictis SA, a Swiss precision medicine company offering tools to optimize drug treatments, is a winner of the European Venture Contest 2015. The company was selected from over 1’000 companies in high technology sector, by an international investors jury composed of over 100 investors and business angels, based on its technology and business opportunity, as one of the most promising companies in Europe in the Life Sciences field.

The contest was organised by Europe Unlimited and took place in Düsseldorf, Germany, on December 7 and 8, 2015.